A review of scores of studies on antidepressants has been retracted because it used an incorrect analysis.
The original paper, published in JAMA Psychiatry on February 19, 2020, looked at individual differences in patients taking antidepressants and concluded that there were significant differences beyond the placebo effect or the data’s statistical noise. The paper earned some attention, including a story on MedPage Today.
However, the analysis didn’t hold up to scrutiny. The retraction notice reads:
A Springer Nature journal has issued an editor’s note — which seems an awful lot like an Expression of Concern — for a widely circulated but quickly contested paper about how the novel coronavirus might infect white blood cells, akin to HIV.
However, readers could be forgiven for missing that fact. Indeed, the journal itself appears to be struggling to deal with the article — which one of the corresponding authors told us he asked to withdraw weeks ago.
A journal has retracted two case reports by a prolific Japanese anesthesiologist who appears to be embroiled in a misconduct investigation.
The two case studies, in JA Clinical Reports, were written by Hironobu Ueshima and Hiroshi Otake, of Showa University Hospital in Tokyo. Ueshima has roughly 170 publications to his name, according to Google Scholar, so we’ll be closely watching for developments in this case.
A series of back and forth publications about a 12-year-old study of nursing education ended with some unusual editorial decisions.
Darrell Spurlock, a professor of nursing at Widener University and director of the university’s Leadership Center for Nursing Education Research, co-authored a study of the Health Education Systems, Inc. (HESI) nursing test in 2008. He and his colleague found that the test was a poor predictor of failure on the National Counsel Licensure Exam (NCLEX-RN).
More than a decade later, a critique of the paper, by Dreher et al., appeared out of the blue, published last year inNursing Forum, a Wiley journal. Spurlock takes issue with the way his research was portrayed in the critique, which paints a more positive picture of the HESI test.
On the heels of retractions of papers based on data that has fallen under intense scrutiny, an emergency medicine group in Africa is withdrawing a tool that they built using data from the same company.
Lee Wallis, one of the editors in chief of the African Journal of Emergency Medicine, described the tool, built in a partnership with the African Federation for Emergency Medicine (AFEM) and Surgisphere, in an April 2, 2020 editorial. A PubPeer commenter noted the potential issues today (June 6), and Wallis responded there nearly immediately to say that the tool was withdrawn.
Two days after issuing expressions of concern about controversial papers on Covid-19, The Lancet and the New England Journal of Medicine have retracted the articles because a number of the authors were not granted access to the underlying data.
The Lancet paper, “Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis,” which relied on data from a private company called Surgisphere and had concluded that hydroxychloroquine was linked to a higher risk of death among some COVID-19 patients, has been dogged by questions since its publication in late May. Some of those complaints led to a correction about aspects of the data, but at the time the authors stood by their conclusions — namely, that hydrochloroquine and chloroquine do not to appear to be effective against the viral infection.
That correction was followed earlier this week by the expression of concern, and now three of the four authors of the article have decided to pull it entirely. The abstaining author, Sapan Desai, is the founder of Surgisphere, whose mission statement declares that the goal of the company is to:
In mid-May, we reported on the retraction of three review articles by Joachim Boldt, whose papers continue to fall despite his having been exposed as a fraudster a decade ago. At the time, we wondered why another journal, Anesthesia & Analgesia, hadn’t also pulled reviews by Boldt that it had published over the years.
A group of researchers in Iran has retracted their case report on what they claimed was the first known case of a pregnant woman who died of Covid-19.
The reason: According to the corresponding author, another group of researchers in Iran, who had first seen the patient at their hospital, had beaten them to the submission punch without their knowledge. (This isn’t the first time we’ve seen a case like this.)
The paper appeared in Travel Medicine and Infectious Disease, an Elsevier title, on April 11. Sometime in early May, it seems (the dates are unclear on the journal website) the group, led by a team at Zanjan University of Medical Sciences, retracted the article.
Elsevier allows authors to withdraw papers without explanation if they have appeared online but not yet in print, which is the case here. So the retraction notice says, well, nothing:
A group of anesthesiology researchers in India has had 10 papers retracted from a single journal because of a “high rate of similarity from various other articles along with overwhelming evidence of data fabrication.”
The retractions came after one of the authors of the papers submitted a manuscript to a different journal whose editor sniffed out issues and raised a red flag.
Richard Fleming, a felon convicted of health care fraud who has been debarred by the US Food and Drug Administration, would like to invite you to participate in a clinical trial.
Fleming has registered a study on ClinicalTrials.gov to evaluate what he calls the “Fleming Method for Tissue and Vascular Differentiation and Metabolism” — a method he claims can help physicians assess pneumonia resulting from Covid-19.
